This article needs additional citations for verification. (June 2022) |
Discipline | Rheumatology |
---|---|
Language | English |
Edited by | Josef Smolen |
Publication details | |
History | 1939–present |
Publisher | BMJ Group on behalf of the European League Against Rheumatism |
Frequency | Monthly |
Delayed, after 12 months | |
27.4 (2022) | |
Standard abbreviations | |
ISO 4 | Ann. Rheum. Dis. |
Indexing | |
CODEN | ARDIAO |
ISSN | 0003-4967 (print) 1468-2060 (web) |
OCLC no. | 746945890 |
Links | |
The Annals of the Rheumatic Diseases is a monthly peer-reviewed medical journal. It is published by the BMJ Group on behalf of the European League Against Rheumatism and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes basic, clinical, and translational research, as well as abstracts from conferences.[1] The journal was established in 1939.[1] Each issue, the editor-in-chief selects a paper to be published open access as an "Editors Choice". The editor-in-chief is Josef Smolen.[1]
The journal publishes lay summaries for patients and non-clinicians that explain the findings and treatment implications arising from key research papers published in the journal. Written by BMJ's Best Health team, they are also checked for accuracy by the journal's editors.
The journal is abstracted and indexed in the Science Citation Index Expanded, Index Medicus, Excerpta Medica, and BIOSIS Previews.[1] According to the Journal Citation Reports, its 2022 impact factor is 27.4.[2]
The journal has been cited most often by: Arthritis & Rheumatism, Annals of the Rheumatic Diseases, Rheumatology, Journal of Rheumatology, and Clinical and Experimental Rheumatology. The journals it has cited most are Arthritis & Rheumatism, Annals of the Rheumatic Diseases, Journal of Rheumatology, Rheumatology, and Journal of Immunology.